Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Midatech Pharma ADR (MTP)

Midatech Pharma ADR (MTP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,519
  • Shares Outstanding, K 3,940
  • Annual Sales, $ 790 K
  • Annual Income, $ -7,510 K
  • 60-Month Beta 2.33
  • Price/Sales 8.36
  • Price/Cash Flow N/A
  • Price/Book 0.30
Trade MTP with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2900 +20.94%
on 11/14/22
2.0100 -22.38%
on 11/14/22
-0.0899 (-5.45%)
since 11/04/22
3-Month
1.2900 +20.94%
on 11/14/22
5.2000 -70.00%
on 09/14/22
-2.1354 (-57.78%)
since 09/02/22
52-Week
1.2900 +20.94%
on 11/14/22
7.4500 -79.06%
on 12/08/21
-4.4899 (-74.21%)
since 12/03/21

Most Recent Stories

More News
Midatech Pharma PLC Announces MTX110 Development for the Treatment of Glioma

Orphan Designation Granted by EMA to MTX110 Development for the Treatment of Glioma

MTP : 1.5601 (-5.71%)
Midatech Pharma PLC Announces Directorate Change

ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 20, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, is...

MTP : 1.5601 (-5.71%)
SAR : 26.13 (-2.61%)
Midatech Pharma PLC Announces Retirement of Chairman and Proposed New Chairman

ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, announces...

MTP : 1.5601 (-5.71%)
SAR : 26.13 (-2.61%)
MXC.LN : 0.650 (-3.70%)
Midatech Pharma PLC - MTX110 Study to be Presented at ISPNO 2022

ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, is...

MTP : 1.5601 (-5.71%)
Midatech Pharma PLC Announces Fast Track Designation for MTX110 Development

Fast Track Designation Granted to MTX110 Development for the Treatment of Recurrent Glioblastoma

MTP : 1.5601 (-5.71%)
Midatech Pharma PLC Announces Posting of Annual Report & Notice of AGM

ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 24, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines,...

MTP : 1.5601 (-5.71%)
Midatech Pharma PLC Announces Results for the Year Ended 31 December 2021

ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 26, 2022 / Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces...

MTP : 1.5601 (-5.71%)
Midatech Pharma PLC Announces Receipt of NASDAQ Notice

ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 14, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines,...

MTP : 1.5601 (-5.71%)
Midpoint Announces Appointment of New CEO/CFO and Results of AGM

LONDON, UK / ACCESSWIRE / April 12, 2022 / Midpoint Holdings Ltd. (TSXV:MPT) (Frankfurt: 8MH1) ("Midpoint" or the "Company") is pleased to announce that all matters presented at its annual general and...

MTP : 1.5601 (-5.71%)
MPT.VN : 0.180 (unch)
Midatech Pharma PLC Announces R&D Collaboration with Janssen on Second Molecule

ABINGDON, UK / ACCESSWIRE / March 9, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is pleased...

MTP : 1.5601 (-5.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Midatech Pharma Plc is focused on the discovery and development of pharmaceutical products of nanomedicine. The Company's product candidates, which are in clinical and pre-clinical development, are Transbuccal Insulin, glucagon-like-peptide, GLP-1/Insulin Combination, Q-Exenatide and Q-Octreotide. Midatech...

See More

Key Turning Points

3rd Resistance Point 1.6874
2nd Resistance Point 1.6710
1st Resistance Point 1.6628
Last Price 1.5601
1st Support Level 1.6382
2nd Support Level 1.6218
3rd Support Level 1.6136

See More

52-Week High 7.4500
Fibonacci 61.8% 5.0969
Fibonacci 50% 4.3700
Fibonacci 38.2% 3.6431
Last Price 1.5601
52-Week Low 1.2900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar